These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4729697)

  • 1. Fibrin-stabilizing factor inhibitors. 8. Pyridine derivatives as charge-transfer complex acceptors.
    Nilsson JL; Hoffmann KJ; Ljunggren C; Stenberg P; Svensson U; Eriksson O; Lundén R
    Acta Pharm Suec; 1973 Jun; 10(3):209-14. PubMed ID: 4729697
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin-stabilizing factor inhibitors. 3. Sulphonamides related to monodansylcadaverine.
    Nilsson JL; Stenberg P; Ljunggren C; Eriksson O; Lundén R
    Acta Pharm Suec; 1971 Nov; 8(5):497-504. PubMed ID: 5159519
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin-stabilizing factor inhibitors. II. The inhibitory properties of various aliphatic amines.
    Stenberg P; Nilsson JL; Eriksson O; Lundén R
    Acta Pharm Suec; 1971 Sep; 8(4):415-22. PubMed ID: 5135175
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin-stabilizing factor inhibitors. IX. An inhibitor assay method based on SDS-disc gel electrophoresis.
    Hoffmann KJ; Ljunggren C; Stenberg P; Nilsson JL
    Acta Pharm Suec; 1973 Sep; 10(4):269-76. PubMed ID: 4759353
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin-stabilizing factor inhibitors. I. Amides and esters of trans-4-(aminomethyl)cyclohexane carboxylic acid (tranexamic acid).
    Nilsson JL; Stenberg P; Eriksson O; Lundén R
    Acta Pharm Suec; 1970 Sep; 7(4):441-8. PubMed ID: 5480084
    [No Abstract]   [Full Text] [Related]  

  • 6. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of cathepsin D in inactivation of platelet factor 4 and the platelet fibrin stabilizing factor].
    Ostrowska H; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():145-52. PubMed ID: 6443813
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 9. An inhibitor to fibrin stabilizing factor (FSF, factor XIII).
    Godal HC
    Scand J Haematol; 1970; 7(1):43-8. PubMed ID: 5447956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of factor XIII as a preventive and therapeutic possibility in atherosclerosis].
    Pola P; Savi L
    Minerva Cardioangiol; 1977; 25(7-8):643-6. PubMed ID: 927657
    [No Abstract]   [Full Text] [Related]  

  • 11. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

  • 12. Design and synthesis of substituted pyridine derivatives as HIF-1alpha prolyl hydroxylase inhibitors.
    Warshakoon NC; Wu S; Boyer A; Kawamoto R; Sheville J; Bhatt RT; Renock S; Xu K; Pokross M; Zhou S; Walter R; Mekel M; Evdokimov AG; East S
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5616-20. PubMed ID: 16908149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin-stabilizing factor inhibitors. 5. Primary amines related to monotosylcadaverine.
    Stenberg P; Ljunggren C; Nilsson JL; Lundén R; Eriksson O
    J Med Chem; 1972 Jun; 15(6):674-5. PubMed ID: 5030935
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrin-stabilizing factor inhibitors. 10. Thiol esters as potent enzyme inhibitors.
    Ljunggren C; Hoffmann KJ; Stenberg P; Nilsson JL
    J Med Chem; 1973 Oct; 16(10):1186-8. PubMed ID: 4749477
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diamines.
    Ljunggren C; Hoffmann KJ; Stenberg P; Svensson U; Nilsson JL; Hartkoorn A; Lundén R
    J Med Chem; 1974 Jun; 17(6):649-51. PubMed ID: 4829944
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor XIII (fibrin-stabilizing factor) and platelets. I. Study of the association of factor XIII with blood platelets.
    Rolović Z
    Acta Med Iugosl; 1968; 22(1):113-23. PubMed ID: 5735663
    [No Abstract]   [Full Text] [Related]  

  • 17. Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives.
    Haginoya N; Kobayashi S; Komoriya S; Hirokawa Y; Furugori T; Nagahara T
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2935-9. PubMed ID: 15125963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitors.
    Hoffmann KJ; Stenberg P; Ljunggren C; Svensson U; Nilsson JL
    J Med Chem; 1975 Mar; 18(3):278-84. PubMed ID: 1133818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 20. Bis(benzimidazole)pyridine derivative as a new class of G-quadruplex inducing and stabilizing ligand.
    Li G; Huang J; Zhang M; Zhou Y; Zhang D; Wu Z; Wang S; Weng X; Zhou X; Yang G
    Chem Commun (Camb); 2008 Oct; (38):4564-6. PubMed ID: 18815684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.